Wooridul Pharmaceutical – World Class Benchmarking
Company: Wooridul Pharmaceutical Limited
Bloomberg ticker: 004720 KS
Market cap: US$260m
Background: Wooridul Pharmaceutical Limited develops and produces medicaments. The company has the following business divisions: ETC Drug, OTC Drug, Obesity Drug, and Health Food. Wooridul Pharmaceutical is headquartered in Hwaseong, Korea.
World Class Benchmarking of Wooridul Pharmaceutical
- Profitable Growth rank of 5 was same compared to the prior period’s 5th rank
- This is average performance compared to 590 small Health Care companies worldwide
- Profitability rank of 5 was better than its Growth rank of 9
- Profitability rank of 5 was the same compared to the prior period’s 5th rank
- This is average performance compared to peers
- Growth rank of 9 was up compared to the prior period’s 10th rank
- This is poor performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.